Literature DB >> 3370743

The effects of antibiotics and uricosuric drugs on the renal elimination of methotrexate and 7-hydroxymethotrexate in rabbits.

H Iven1, H Brasch.   

Abstract

In anesthetized rabbits, continuous infusion of methotrexate (MTX; 30 micrograms kg-1 min-1) established steady-state plasma concentrations for MTX and the metabolite 7-hydroxymethotrexate (7-OH-MTX) within 40 min. Fifty percent of the infused dose was eliminated unchanged by the kidneys and the renal MTX clearance was slightly higher than the inulin clearance. Another 15%-30% was metabolized and excreted as 7-OH-MTX in the urine. Infusions of 7-OH-MTX, furosemide or benzarone had no influence on the clearance of MTX or 7-OH-MTX. Infusions of probenecid or piperacillin decreased the renal clearance of MTX and 7-OH-MTX mainly by reducing the tubular secretion of both compounds. In contrast, infusions of the antibiotics ceftriaxone and sulfamethoxazole increased the renal elimination of MTX and 7-OH-MTX. An increase was also observed during the infusion of the uricosuric drugs sulfinpyrazone and benzbromarone. These results are consistent with competition for tubular reabsorption between MTX, ceftriaxone and sulfamethoxazole. The pharmacokinetic drug interactions observed occurred with therapeutic drug concentrations and thus may be clinically relevant.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3370743     DOI: 10.1007/bf00264201

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  30 in total

1.  Drug interaction in psoriasis.

Authors:  J D Adams; G A Hunter
Journal:  Australas J Dermatol       Date:  1976-08       Impact factor: 2.875

2.  Biliary secretion of methotrexate in rats and its inhibition by probenecid.

Authors:  R E Kates; T N Tozer
Journal:  J Pharm Sci       Date:  1976-09       Impact factor: 3.534

Review 3.  Methotrexate disposition in humans: case studies in ovarian cancer and following high-dose infusion.

Authors:  B A Chabner; R G Stoller; K Hande; S Jacobs; R C Young
Journal:  Drug Metab Rev       Date:  1978       Impact factor: 4.518

Review 4.  High-dose methotrexate therapy--an area of uncertainty.

Authors:  J W Paxton
Journal:  Aust N Z J Med       Date:  1979-12

5.  The effect of organic acids on renal clearance of methotrexate in man.

Authors:  D G Liegler; E S Henderson; M A Hahn; V T Oliverio
Journal:  Clin Pharmacol Ther       Date:  1969 Nov-Dec       Impact factor: 6.875

6.  [Effect of benzbromarone on serum uric acid level and uric acid excretion of patients with gout].

Authors:  N Zöllner; A Griebsch; J K Fink
Journal:  Dtsch Med Wochenschr       Date:  1970-11-27       Impact factor: 0.628

7.  Pharmacokinetics of high-dose methotrexate with citrovorum factor rescue.

Authors:  W H Isacoff; P F Morrison; J Aroesty; K L Willis; J B Block; T L Lincoln
Journal:  Cancer Treat Rep       Date:  1977-12

8.  Renal tubular transport of methotrexate in the rhesus monkey and dog.

Authors:  K C Huang; B A Wenczak; Y K Liu
Journal:  Cancer Res       Date:  1979-12       Impact factor: 12.701

9.  Interaction of probenecid with the protein binding of methotrexate.

Authors:  J W Paxton
Journal:  Pharmacology       Date:  1984       Impact factor: 2.547

10.  7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate.

Authors:  S A Jacobs; R G Stoller; B A Chabner; D G Johns
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

View more
  3 in total

1.  Cephalosporins increase the renal clearance of methotrexate and 7-hydroxymethotrexate in rabbits.

Authors:  H Iven; H Brasch
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Pharmacokinetics of methotrexate (MTX) and 7-hydroxymethotrexate (7-OH-MTX) in rats and evidence for the metabolism of MTX to 7-OH-MTX.

Authors:  L Fahrig; H Brasch; H Iven
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

3.  Impact of omeprazole on the plasma clearance of methotrexate.

Authors:  T Reid; A Yuen; M Catolico; R W Carlson
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.